Clinical trial
A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
NCT04679883 is registered in ClinicalTrials.gov with GL Pharm Tech Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
- Lead sponsor
- GL Pharm Tech Corporation
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 1, 2021
- Completion date
- April 30, 2022
- Enrollment
- 99 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.